Donaldson Company Acquires Solaris Biotechnology

The acquisition will position Donaldson to provide more comprehensive solutions to food and beverage customers and expand its access to biopharma and other key life sciences markets.

Solaris Porto Mantovano, Italy Location
Solaris Porto Mantovano, Italy Location

Donaldson Company, a leading worldwide provider of innovative filtration products and solutions, has acquired Solaris Biotechnology Srl (“Solaris”). Solaris designs and manufactures bioprocessing equipment, including bioreactors, fermenters, and tangential flow filtration systems for use in food and beverage, biotechnology, and other life sciences markets. Solaris’ product portfolio ranges from benchtop systems for research and development to pilot and commercial-scale manufacturing systems.

“We are excited about Solaris’ capabilities and growth trajectory, and this acquisition is an important step on our journey towards strengthening our presence in the life sciences market,” says Tod Carpenter, chairman, president, and chief executive officer of Donaldson. “With Solaris, we are well-positioned to provide more comprehensive solutions to food and beverage customers and expand our access to biopharma and other key life sciences markets. We are committed to building our presence in these markets, and this acquisition, combined with a strong pipeline of opportunities for both focused organic growth and additional acquisitions, gives us confidence we can deliver on our strategic priorities while creating value for our stakeholders.”

“By being part of Donaldson, we will have the global scale and financial flexibility to continue delivering on our growth plans, and we are thrilled about this opportunity,” adds Matteo Brognoli, co-founder and chief executive officer of Solaris. “Like Donaldson, Solaris is built on strong customer relationships and providing technologically advanced solutions. With the need for Solaris products expanding rapidly, we are better able to meet the growing need while playing an important role in Donaldson’s expansion into life sciences.” Brognoli will remain with the company to lead Solaris as managing director with responsibility for day-to-day operations and continued growth of the business.

Solaris was founded in 2002 and is headquartered in Porto Mantovano, Italy, with U.S. operations based in Berkeley, Calif. The company has approximately 30 employees. Donaldson has acquired Solaris for approximately €41 million.


COVID: Lessons Learned
New report recommends that your next facility should be designed to minimize disease exposure.
Free Download
COVID: Lessons Learned
Test Your Smarts
Take ProFood World's food safety quiz to prove your knowledge!
Take Quiz
Test Your Smarts